At a Glance
Dosage
Only in MiPLA
oral
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 100–150 µg |
| Common | 150–200 µg |
| Strong | 200–250 µg |
| Heavy | 300 µg |
Only in 25B-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong |
Duration
Only in MiPLA
oral
Come Up
Peak
Offset
Onset: 20 min – 40 minCome Up: 45 min – 1.5 hrsPeak: 1 hrs – 2 hrsOffset: 1 hrs – 2 hrs
Total: 4 hrs – 6 hrs
Only in 25B-NBOMe
sublingual
Peak
Offset
Effects
Safety
Interaction: MiPLA + 25B-NBOMe
No direct interaction data available between these substances. This does not mean the combination is safe.
MiPLA — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between MiPLA and 25B-NBOMe?
MiPLA is classified as a Psychedelic (Lysergamides) while 25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 30 effects in common, with 20 effects unique to MiPLA and 7 unique to 25B-NBOMe.
Is it safe to combine MiPLA and 25B-NBOMe?
There is no direct interaction data available for combining MiPLA and 25B-NBOMe. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, MiPLA or 25B-NBOMe?
MiPLA and 25B-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.